DYA Fundamental Analysis - DYNACERT INC

Fundamental Rating

We assign a fundamental rating of 2 out of 10 to DYA. DYA was compared to 16 industry peers in the Electrical Equipment industry. Both the profitability and financial health of DYA have multiple concerns. DYA has a decent growth rate and is not valued too expensively.

Quickly go to:

1. Profitability

1.1 Basic Checks

DYA had negative earnings in the past year.

In the past year DYA has reported a negative cash flow from operations.

In the past 5 years DYA always reported negative net income.

In the past 5 years DYA always reported negative operating cash flow.

1.2 Ratios

With a Return On Assets value of -164.37%, DYA is not doing good in the industry: 75.00% of the companies in the same industry are doing better.

The Return On Equity of DYA (-737.45%) is worse than 81.25% of its industry peers.

		Industry Rank	Sector Rank
ROA	-164.37%
ROE	-737.45%
ROIC	N/A

ROA(3y)-201.12%

ROA(5y)-150.07%

ROE(3y)N/A

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

DYA does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	N/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

DYA does not have a ROIC to compare to the WACC, probably because it is not profitable.

The number of shares outstanding for DYA has been increased compared to 1 year ago.

DYA has more shares outstanding than it did 5 years ago.

The debt/assets ratio for DYA is higher compared to a year ago.

2.2 Solvency

Based on the Altman-Z score of -23.90, we must say that DYA is in the distress zone and has some risk of bankruptcy.

Looking at the Altman-Z score, with a value of -23.90, DYA is doing worse than 75.00% of the companies in the same industry.

DYA has a Debt/Equity ratio of 1.58. This is a high value indicating a heavy dependency on external financing.

With a Debt to Equity ratio value of 1.58, DYA is not doing good in the industry: 81.25% of the companies in the same industry are doing better.

		Industry Rank	Sector Rank
Debt/Equity	1.58
Debt/FCF	N/A
Altman-Z	-23.9

ROIC/WACCN/A

WACC7.61%

2.3 Liquidity

DYA has a Current Ratio of 0.97. This is a bad value and indicates that DYA is not financially healthy enough and could expect problems in meeting its short term obligations.

The Current ratio of DYA (0.97) is worse than 62.50% of its industry peers.

A Quick Ratio of 0.59 indicates that DYA may have some problems paying its short term obligations.

DYA's Quick ratio of 0.59 is on the low side compared to the rest of the industry. DYA is outperformed by 68.75% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	0.97
Quick Ratio	0.59

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 8.37% over the past year.

The Revenue for DYA has decreased by -48.39% in the past year. This is quite bad

Measured over the past years, DYA shows a quite strong growth in Revenue. The Revenue has been growing by 8.61% on average per year.

EPS 1Y (TTM)8.37%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%49.35%

Revenue 1Y (TTM)-48.39%

Revenue growth 3Y28.22%

Revenue growth 5Y8.61%

Sales Q2Q%-67.18%

3.2 Future

The Earnings Per Share is expected to grow by 55.65% on average over the next years. This is a very strong growth

The Revenue is expected to grow by 263.86% on average over the next years. This is a very strong growth

EPS Next Y100%

EPS Next 2Y55.65%

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next Year656.55%

Revenue Next 2Y263.86%

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for DYA. In the last year negative earnings were reported.

With a Price/Forward Earnings ratio of 8.42, the valuation of DYA can be described as very reasonable.

81.25% of the companies in the same industry are more expensive than DYA, based on the Price/Forward Earnings ratio.

The average S&P500 Price/Forward Earnings ratio is at 23.68. DYA is valued rather cheaply when compared to this.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	8.42

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

DYA's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.

A more expensive valuation may be justified as DYA's earnings are expected to grow with 55.65% in the coming years.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y55.65%

EPS Next 3YN/A

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

DYA does not give a dividend.

		Industry Rank	Sector Rank
Dividend Yield	0%

More info and screens

Find the best dividend stocks

Show peers with best dividend

DYNACERT INC

TSX:DYA (12/17/2025, 7:00:00 PM)

0.085

0 (-5.56%)

Chartmill FA Rating

GICS SectorIndustrials

GICS IndustryGroupCapital Goods

GICS IndustryElectrical Equipment

Earnings (Last)11-13 2025-11-13

Earnings (Next)03-26 2026-03-26

Inst Owners3.23%

Inst Owner ChangeN/A

Ins Owners6.6%

Ins Owner ChangeN/A

Market Cap43.20M

Revenue(TTM)765.00K

Net Income(TTM)-10.10M

Analysts84

Price Target0.77 (805.88%)

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	0%

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)0%

PT rev (3m)0%

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)N/A

EPS NY rev (3m)N/A

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)0%

Revenue NY rev (3m)0%

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	8.42
P/S	56.48
P/FCF	N/A
P/OCF	N/A
P/B	31.54
P/tB	54.5
EV/EBITDA	N/A

EPS(TTM)-0.02

EYN/A

EPS(NY)0.01

Fwd EY11.88%

FCF(TTM)-0.02

FCFYN/A

OCF(TTM)-0.02

OCFYN/A

SpS0

BVpS0

TBVpS0

PEG (NY)N/A

PEG (5Y)N/A

Graham NumberN/A

Profitability

		Industry Rank	Sector Rank
ROA	-164.37%
ROE	-737.45%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	N/A
FCFM	N/A

ROA(3y)-201.12%

ROA(5y)-150.07%

ROE(3y)N/A

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexgc growth 3YN/A

ROICexgc growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

F-Score4

Asset Turnover0.12

Health

		Industry Rank	Sector Rank
Debt/Equity	1.58
Debt/FCF	N/A
Debt/EBITDA	N/A
Cap/Depr	2.06%
Cap/Sales	2.14%
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	0.97
Quick Ratio	0.59
Altman-Z	-23.9

F-Score4

WACC7.61%

ROIC/WACCN/A

Cap/Depr(3y)6.19%

Cap/Depr(5y)101.41%

Cap/Sales(3y)7.56%

Cap/Sales(5y)101.33%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)8.37%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%49.35%

EPS Next Y100%

EPS Next 2Y55.65%

EPS Next 3YN/A

EPS Next 5YN/A

Revenue 1Y (TTM)-48.39%

Revenue growth 3Y28.22%

Revenue growth 5Y8.61%

Sales Q2Q%-67.18%

Revenue Next Year656.55%

Revenue Next 2Y263.86%

Revenue Next 3YN/A

Revenue Next 5YN/A

EBIT growth 1Y-10.35%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next Year117.62%

EBIT Next 3YN/A

EBIT Next 5YN/A

FCF growth 1Y-156.01%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y-160.31%

OCF growth 3YN/A

OCF growth 5YN/A

DYNACERT INC / DYA.CA FAQ

Can you provide the ChartMill fundamental rating for DYNACERT INC?

ChartMill assigns a fundamental rating of 2 / 10 to DYA.CA.

What is the valuation status for DYA stock?

ChartMill assigns a valuation rating of 4 / 10 to DYNACERT INC (DYA.CA). This can be considered as Fairly Valued.

What is the profitability of DYA stock?

DYNACERT INC (DYA.CA) has a profitability rating of 0 / 10.

How financially healthy is DYNACERT INC?

The financial health rating of DYNACERT INC (DYA.CA) is 0 / 10.

DYNACERT INC (DYA.CA) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens

DYNACERT INC / DYA.CA FAQ

Can you provide the ChartMill fundamental rating for DYNACERT INC?

What is the valuation status for DYA stock?

What is the profitability of DYA stock?

How financially healthy is DYNACERT INC?